CAS: 1809068-70-9
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | N-[(1S,2S,3R)-3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)-2-hydroxycyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide REF: 3D-JXC06870CAS: 1809068-70-9 | Min. 95% | 453,00 €~4.405,00 € | Ter 21 Jan 25 |
 | SMAP-2 REF: TM-T12934CAS: 1809068-70-9 | 98% | A consultar | Seg 27 Jan 25 |
![N-[(1S,2S,3R)-3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)-2-hydroxycyclohexyl]-4-(trifluoromethoxy)…](https://static.cymitquimica.com/products/3D/thumb/JXC06870.jpg)
N-[(1S,2S,3R)-3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)-2-hydroxycyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide
CAS:1809068-70-9
Please enquire for more information about N-[(1S,2S,3R)-3-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)-2-hydroxycyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide including the price, delivery time and more detailed …
Fórmula:
C27H27F3N2O4S
Pureza:
Min. 95%
Peso molecular:
532.6 g/mol
Ref: 3D-JXC06870
| 1mg | 453,00 € | ||
| 2mg | 711,00 € | ||
| 5mg | 1.276,00 € | ||
| 10mg | 1.855,00 € | ||
| 25mg | 4.405,00 € |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
SMAP-2
CAS:1809068-70-9
SMAP-2: oral PP2A activator, targets Aα subunit, halts KRAS-mutant lung cancer growth.
Fórmula:
C27H27F3N2O4S
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
532.57
Ref: TM-T12934
| 25mg | 1.410,00 € | ||
| 50mg | 1.845,00 € | ||
| 100mg | 2.329,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 27 de Janeiro de 2025
